STUDY BASICS
Do you have primary biliary cholangitis (also known as primary biliary cirrhosis or PBC)? If so, you may be eligible to participate in a study to help researchers find out how the study drug, Obeticholic Acid, is absorbed, distributed, and excreted from the body. Involves at least 19 visits over 3 years. Compensation is provided.
IRB: SSU00070765
- Intercept Pharmaceuticals, Inc. – 747-401, A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients with Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment (Pro00024186)
DURATION:
3 years
VISITS:
19 visits
LOCATION:
UPMC Montefiore Hospital - Oakland
COMPENSATION:
$50 & a parking voucher for each completed visit
PHONE NUMBER: 1-866-438-8230
INTERESTED?
Visit https://pittplusme.org/study/1500 and click on "I'm Interested" or call 1-866-438-8230.
LEARN MORE
PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe